Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel macrolides through genetic engineering.

L Katz1, R McDaniel

  • 1Kosan Biosciences, Inc., Hayward, California 94545, USA. katz@kosan.com

Medicinal Research Reviews
|November 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multifunctional matching algorithm for sample design in agricultural plots.

Computers and electronics in agriculture·2021
Same author

A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancer.

Familial cancer·2021
Same author

Clinical characteristics and risk factors for mortality in obstetric patients with severe COVID-19 in Brazil: a surveillance database analysis.

BJOG : an international journal of obstetrics and gynaecology·2020
Same author

Prevalence of blood donor iron deficiency and feasibility ferritin-based iron replacement: a blood collection agency-based study.

Vox sanguinis·2016
Same author

AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes.

Diabetes, obesity & metabolism·2015
Same author

Randomised clinical trial: Polyethylene glycol 3350 with sports drink vs. polyethylene glycol with electrolyte solution as purgatives for colonoscopy--the incidence of hyponatraemia.

Alimentary pharmacology & therapeutics·2014

Genetic engineering of erythromycin biosynthesis via polyketide synthases (PKS) allows for novel antibiotic structures. This approach offers predictable modifications not achievable through traditional chemical synthesis methods.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Microbiology

Background:

  • Erythromycin is a macrolide antibiotic produced by Saccharopolyspora erythraea.
  • Its biosynthesis involves a complex polyketide synthase (PKS) enzyme system.

Purpose of the Study:

  • To explore the potential of genetic manipulation of PKS genes for generating novel erythromycin structures.
  • To investigate an alternative to traditional chemical synthesis for antibiotic modification.

Main Methods:

  • Cloning and sequencing of genes encoding PKS enzymes.
  • Genetic manipulation of PKS-encoding genes.
  • Analysis of resulting structural changes in erythromycin.

Main Results:

  • Genetic engineering of PKS genes leads to predictable alterations in the polyketide backbone of erythromycin.

Related Experiment Videos

  • These modifications are often not feasible via standard chemical synthesis.
  • Combinations of genetic changes can yield entirely new molecular structures.
  • Conclusions:

    • Genetic manipulation of PKS offers a powerful strategy for creating novel erythromycin analogs.
    • This approach holds promise for discovering new antibiotics by engineering PKS pathways for other complex polyketides.